Recombinant human cytochrome P450 1B1 expression in Escherichia coli

被引:90
|
作者
Shimada, T
Wunsch, RM
Hanna, IH
Sutter, TR
Guengerich, FP [1 ]
Gillam, EMJ
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Div Toxicol Sci, Baltimore, MD 21205 USA
[4] Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia
关键词
P450; 1B1; 1Al; 1A2; carcinogens; heterocyclic amines; heterologous expression; estradiol; bicistronic constructs;
D O I
10.1006/abbi.1998.0808
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cytochrome P450 (P450) 1B1 was expressed in Escherichia coli at a level of 200 nmol/liter culture using a pCW vector by removal of codons 2-4 and modification of the nucleotide sequence of the resulting N-terminal seven codons; a similar level of expression was found with a bicistronic construct that also expressed human NADPH-P450 reductase, P450 1B1 was purified (from the monocistronic system) to electrophoretic homogeneity and a specific content of 9.2 nmol P450/mg protein using DEAE, CM, and hydroxylapatite chromatography, The absolute spectra showed a considerable fraction of high-spin iron and little cytochrome P420, The catalytic activity of the purified enzyme was considerably enhanced in the presence of cholate. Both reconstituted P450 1B1 and the bacterial membranes prepared from the bicistronic vector system had similar 7-ethoxyresorufin O-deethylation activities; as expected, 17 beta-estradiol was hydroxylated primarily at the 4-position. The ability of human P450 1B1 to activate several heterocyclic amines and polycyclic hydrocarbon dihydrodiols was confirmed with reconstituted P450 1B1 and the P450 1B1 membranes in which NADPH-P450 reductase was coexpressed. (C) 1998 Academic Press.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [1] Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
    Shimada, T
    Gillam, EMJ
    Sutter, TR
    Strickland, PT
    Guengerich, FP
    Yamazaki, H
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (05) : 617 - 622
  • [2] Cancer activation and polymorphisms of human cytochrome P450 1B1
    Chun Y.-J.
    Kim D.
    Toxicological Research, 2016, 32 (2) : 89 - 93
  • [3] Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene
    Chun, Young-Jin
    Oh, Young-Kun
    Kim, Beom Joon
    Kim, Donghak
    Kim, Sung Su
    Choi, Hyung-Kyoon
    Kim, Mie-Young
    TOXICOLOGY LETTERS, 2009, 189 (01) : 84 - 89
  • [4] Modulation of cytochrome P450 1B1 by tetramethoxystilbene
    Chun, Y. J.
    Oh, Y. K.
    Kim, D.
    Kim, M. Y.
    TOXICOLOGY LETTERS, 2010, 196 : S111 - S111
  • [5] Inhibitors of cytochrome P450 (CYP) 1B1
    Dutour, Raphael
    Poirier, Donald
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 135 : 296 - 306
  • [7] Cytochrome P450 1B1:: A major P450 isoenzyme in human blood monocytes and macrophage subsets
    Baron, JM
    Zwadlo-Klarwasser, G
    Jugert, F
    Hamann, W
    Rübben, A
    Mukhtar, H
    Merk, HF
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (09) : 1105 - 1110
  • [8] Cytochrome P450 1B1 mRNA in the human central nervous system
    Rieder, CRM
    Ramsden, DB
    Williams, AC
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (03): : 138 - 142
  • [9] Expression of recombinant human cytochrome P450 1A2 in Escherichia coli bacterial mutagenicity tester strain
    Chun, YJ
    ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (03) : 305 - 309
  • [10] Identification of inhibitors of Cytochrome P450 (CYP) 1B1
    Roach, Tyler
    Kennedy, Larry
    FASEB JOURNAL, 2016, 30